Clinical Trials in Malmo, Sweden
1 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast NeoplasmsTriple Negative Breast NeoplasmsHR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC2,400 enrolled234 locationsNCT06966700
Recruiting
Phase 2Phase 3
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Breast Neoplasms
Bristol-Myers Squibb500 enrolled293 locationsNCT06926868
Recruiting
Phase 3
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Prostate Cancer
AstraZeneca700 enrolled328 locationsNCT06952803
Recruiting
Phase 2
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
Breast Cancer
Karolinska University Hospital370 enrolled7 locationsNCT05900206
Recruiting
On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
Metastatic Colorectal CancerChemotherapy EffectPeritoneal Metastases+2 more
Region Skane100 enrolled2 locationsNCT05755672
Recruiting
Not Applicable
A Trial on the Use of Point-of-care Ultrasound in the Assessment of Breast Symptoms
Breast Cancer
Region Skane600 enrolled1 locationNCT06932133
Recruiting
Not Applicable
Clinical Explorative Optical Breast Investigations
Benign Breast TumorsMalignant Breast TumoursHealthy
Region Skane90 enrolled1 locationNCT06857669
Recruiting
Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer
Breast Neoplasms
Lund University20,000 enrolled9 locationsNCT02306096